Related Experiment Video
Updated: Jun 8, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina
Edgardo Gabriel Bottaro1, Mara Judith Huberman, María Del Carmen Iannella
1Helios Salud and Hospital General de Agudos Donación F. Santojanni, Buenos Aires, Argentina. egbottaro@gmail.com
Objectives:
to determine the incidence and risk factors for nevirapine (NVP)-associated toxicity in a cohort of HIV-infected people in Buenos Aires, Argentina.
Design:
retrospective study.
Methods:
HIV-infected adults who received NVP-based highly active antiretroviral therapy (HAART) at least for 2 weeks between May 1997 and March 2008 were included in this study. We analyzed patients' age, gender, HIV transmission route, HIV disease stage, pregnancy, alcohol intake, adverse events, coinfection with hepatitis B or C virus, time until toxicity, and withdrawal rates.
Results:
a total of 1110 patients (631 men) were included. Rash was the most frequently observed adverse event; it was more frequent in women. The incidence of severe rash and hepatotoxicity was similar in women and men. Female sex was the only variable significantly associated with mild-to-moderate rash. High CD4 count, pregnancy, and chronic hepatitis were not associated with NVP-related toxicity. An undetectable viral load at the time of starting NVP treatment resulted in a lower risk of NVP-related rash.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Drug Toxicity: Risk factors
Drug toxicity: Idiosyncratic Reactions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Teratogenicity
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
